Dr. Hagen Richter joined WACKER in 2016 and currently serves as Head of Nucleic Acids Research with the WACKER central R&D hub in Munich, Germany. His team of approximately 30 scientific and technical experts focuses on research innovations and both academic and industry collaborations to advance Wacker Biotech’s capabilities in advanced therapy and vaccine development and manufacturing across the pDNA – RNA – LNP value chain.

After earning a Ph.D. in Molecular Biology and a Master of Science in Biotechnology from The Philipp University of Marburg, Dr. Richter was a Postdoctoral Fellow with Nobel Laureate Prof. Dr. Emmanuelle Charpentier at the Max-Planck Institute of Infection Biology and Helmholtz Center for Infection Research. He has co-authored 14 peer-reviewed scientific publications. His academic research has focused on small regulatory RNAs in pathogenesis of Yersinia pseudotuberculosis, DNA replication in Saccharomyces cerevisiae, and CRISPR RNA maturation in Methanoccus maripaludis and Francisella novicida.